These are some of the stocks posting the largest moves midday.
— The Danish drugmaker stock added 5.5% after saying late Tuesday it was halting Ozempic's kidney disease treatment trial after a committee said an analysis showed signs of success.— Shares of dialysis services providers DaVita and Fresenius Medical Care sank 18.4% and 19.6%, respectively, on Novo Nordisk's news. Baxter International, which makes products for chronic dialysis therapies, slid 9%.shale rival Pioneer Natural Resources for $59.
The No. 1 thing CEOs are investing in right now, says a new survey—you can use it to get a lucrative jobthat Japanese companies will invest $1 billion in Coherent's silicon carbide business. On Wednesday, B. Riley upgraded shares to buy from neutral, saying Coherent's silicon carbide business could be worth more than the Street's current estimate.— The battery company climbed 3.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon, Amgen and moreThese are some of the stocks posting the largest moves midday.
Baca lebih lajut »
Stock movers: DaVita, Exxon Mobil, Ozempic drug parent Novo NordiskExxon Mobil stock falls after the oil giant announces a $59.5 billion all-stock deal to buy Pioneer Natural Resources
Baca lebih lajut »
Stock movers: Novo Nordisk, Fresenius Medical Care, DaVita, Thor IndustriesNovo Nordisk, Thor Industries, Silk Road Medical, Fresenius Medical Care, and DaVita all showed stock price movement in pre-market trading
Baca lebih lajut »
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and moreThese are the stocks posting the largest moves in premarket trading.
Baca lebih lajut »
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and moreThese are the stocks posting the largest moves in premarket trading.
Baca lebih lajut »
Novo Nordisk, Eli Lilly leap as Ozempic show promise in kidney patient treatmentOzempic, the diabetes treatment often prescribed for weight loss, is also proving highly-effective in treating patients with chronic kidney disease.
Baca lebih lajut »